Cargando…

The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer

Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3), the mammalian ortholog of yeast vesicular protein sorting 34 (Vps34), belongs to the phosphoinositide 3-kinase (PI3K) family. PIK3C3 can phosphorylate phosphatidylinositol (PtdIns) to generate phosphatidylinositol 3-phosphate (PI3P), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Chien-An, Wang, Yi-Wen, Chen, Yi-Lin, Chen, Hui-Wen, Chuang, Jing-Jing, Chang, Hong-Yi, Ho, Chung-Liang, Chang, Chen, Chow, Nan-Haw, Lee, Chung-Ta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535862/ https://www.ncbi.nlm.nih.gov/pubmed/34681622 http://dx.doi.org/10.3390/ijms222010964

Ejemplares similares

MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway
por: Chu, Chien-An, et al.
Publicado: (2019)

Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours
por: CAPODANNO, ALESSANDRA, et al.
Publicado: (2012)

The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma
por: Pridham, Kevin J., et al.
Publicado: (2017)

Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer
por: Toppmeyer, Deborah L., et al.
Publicado: (2020)

Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review
por: Sun, Guojuan, et al.
Publicado: (2022)

Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells
por: Folgiero, V, et al.
Publicado: (2012)

Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma
por: Zeng, Chuanli, et al.
Publicado: (2022)

Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling
por: Chang, Jun-Hei, et al.
Publicado: (2020)

The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
por: Wang, Yi-Wen, et al.
Publicado: (2021)

Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma
por: Yang, Hang, et al.
Publicado: (2015)

Inhibitors of Phosphatidylinositol 3′-Kinases Promote Mitotic Cell Death in HeLa Cells
por: Hou, Heli, et al.
Publicado: (2012)

The class IA phosphatidylinositol 3-kinase p110-β subunit is a positive regulator of autophagy
por: Dou, Zhixun, et al.
Publicado: (2010)

Structure of 85 kDa Subunit of Human Phosphatidylinositol 3‐Kinase Analyzed by Using Monoclonal Antibodies
por: Tanaka, Shinya, et al.
Publicado: (1993)

Autophagy Restricts Proliferation Driven By Oncogenic Phosphatidylinositol 3-Kinase in Three-Dimensional Culture
por: Chen, Nan, et al.
Publicado: (2012)

Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation
por: Zhao, Hua-fu, et al.
Publicado: (2021)

Bacillus subtilis Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants via the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta–Serine/Threonine Kinase–Mammalian Target of Rapamycin Complex 1 Pathway
por: Wang, Qiuju, et al.
Publicado: (2022)

Retracted: Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review
por: and Biomechanics, Applied Bionics
Publicado: (2023)

A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation
por: Clayton, Elizabeth, et al.
Publicado: (2002)

Subunit P60 of phosphatidylinositol 3-kinase promotes cell proliferation or apoptosis depending on its phosphorylation status
por: Di, Yu-Qin, et al.
Publicado: (2021)

Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation
por: Zhao, Hua‑fu, et al.
Publicado: (2021)

Synthesis of Pelorol and Its Analogs and Their Inhibitory Effects on Phosphatidylinositol 3-Kinase
por: Luo, Yongjie, et al.
Publicado: (2016)

Resveratrol Inhibits LPS-Induced MAPKs Activation via Activation of the Phosphatidylinositol 3-Kinase Pathway in Murine RAW 264.7 Macrophage Cells
por: Zong, Yi, et al.
Publicado: (2012)

Structural basis of phosphatidylinositol 3-kinase C2α function
por: Lo, Wen-Ting, et al.
Publicado: (2022)

Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway
por: Zhang, Haijun, et al.
Publicado: (2021)

Phosphatidylinositol 3 kinase modulation of trophoblast cell differentiation
por: Kent, Lindsey N, et al.
Publicado: (2010)

Architecture and dynamics of the autophagic phosphatidylinositol 3-kinase complex
por: Baskaran, Sulochanadevi, et al.
Publicado: (2014)

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
por: Cohen, Jeffrey I.
Publicado: (2018)

Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia
por: Goncalves, Marcus D., et al.
Publicado: (2022)

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells
Publicado: (1995)

Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway
por: Lyu, Wen-Jie, et al.
Publicado: (2020)

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
por: Lo, Wen-Ting, et al.
Publicado: (2022)

DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein
por: An, Jing, et al.
Publicado: (2008)

Enhanced Cell Killing by Overexpression of Dominant‐negative Phosphatidylinositol 3‐Kinase Subunit, Δp85, Following Genotoxic Stresses
por: Tachiiri, Seiji, et al.
Publicado: (2000)

Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway
por: YUAN, XUN, et al.
Publicado: (2014)

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
por: Stevens, K N, et al.
Publicado: (2011)

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma
por: Zhang, Hong-Xia, et al.
Publicado: (2015)

Phosphatidylinositol 3-Kinase Is a Negative Regulator of Cellular Differentiation
por: Ptasznik, Andrzej, et al.
Publicado: (1997)

Multiple Phosphatidylinositol 3-Kinases Regulate Vaccinia Virus Morphogenesis
por: McNulty, Shannon, et al.
Publicado: (2010)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_15fco24igngfk8l0nbm3ab3lqk